Effects of antidepressant treatments on polymorphonuclear elastase levels in patients with depression

Journal of Affective Disorders

Volumn 59, Issue 3, 2000, Pages 175-182

  Bekaroglu, M ^a   Deger, O ^a   Karahan, S C ^a   Bilici, M ^a   Soylu, C ^a   Orem A ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Antidepressant treatment; Depression; PMN elastase

Indexed keywords

ELASTASE; IMIPRAMINE; MOCLOBEMIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE MARKER; DISEASE SEVERITY; DYSTHYMIA; ENZYME BLOOD LEVEL; ENZYME RELEASE; FEMALE; HAMILTON SCALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BIOLOGICAL MARKERS; DEPRESSIVE DISORDER, MAJOR; DYSTHYMIC DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMIPRAMINE; LEUKOCYTE COUNT; LEUKOCYTE ELASTASE; MALE; MOCLOBEMIDE; NEUTROPHILS; TREATMENT OUTCOME;

EID: 0034038108     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(99)00117-2     Document Type: Article

References (35)

1. Akyol N., Deger O., Erdöl H., Gedik Y., Örem A., Imamoglu H.I. The importance of plasma polymorphonuclear (PMN) elastase determination in patients with uveitis. Acta Ophthalmol. Scand. 75:1997;287-289.
2. Diagnostic and Statistical Manual of Mental Disorders. 4th ed :1994;American Psychiatric Association, Washington DC.
3. Bauer M.E., Gauer G.J., Luz C., Silveira R.O., Nardi N.B., Von Muhlen C.A. Evaluation of immune parameters in depressed patients. Life Sci. 57:1995;665-674.
4. Bieth J.G. Robert L., Hornebeck W. Elastin and Elastases. Human neutrophil elastase. Vol. 2:1989;23-31 CRC Press, Boca Raton, FL.
5. Calabrese J.R., Skwerer R.G., Barna B., Gulledge A.D., Valenzuela R., Butkus A., Subichin S., Krupp N.F. Depression, immunocompetence, and prostaglandins of the E series. Psychiatry Res. 17:1986;41-47.
6. Dawson-Saunders B., Trapp R.G. Basic & Clinical Biostatistics. 1994;Prentice Hall International, London.
7. Deger O., Örem A., Akyol N., Bahadir S., Yildirmiş S. Polymorphonuclear leukocyte elastase levels in patients with Behçet's disease. Clin. Chim. Acta. 236:1995;129-134.
8. Deger O., Bekaroglu M., Örem A., Orem S., Uluutku N., Soylu C. Polymorphonuclear (PMN) elastase levels in depressive disorders. Biol. Psychiatry. 39:1996;357-363.
9. 1-proteinase-inhibitor complex using a homogenous and heterogenous enzyme-immunoassay. J. Clin. Chem. Clin. Biochem. 27:1989;868-871.
10. Gardinali M., Padalino P., Vesconi S., Calcapno A., Ciappelano S., Conciato L., et al. Complement activation and polymorphonuclear leukocyte elastase in sepsis: Correlation with severity of disease. Arch. Surg. 127:1992;1219-1224.
11. Gross V., Schölmerich J., Leser H.G., Salm R., Lausen M., Rackauer K., et al. Granulocyte elastase in assessment of severity of acute pancreatitis. Dig. Dis. Sci. 35:1990;97-105.
12. Hastka J. The importance of granulocyte elastase in haematological diagnosis. Blut. 57:1988;69-75.
13. Hyman S.E., Nestler E.J. The Molecular Foundations of Psychiatry. 1993;133-135 American Psychiatric Press, Inc, Washington, DC.
14. Joyce P.R., Hawes C.R., Mulder R.T., Sellman J.D., Wilson D.A., Boswell D.R. Elevated levels of acute phase plasma proteins in major depression. Biol. Psychiatry. 32:1992;1035-1041.
15. 1-protease inhibitor complex in patients with rheumatoid arthritis. Rheumatol. Int. 10:1990;51-56.
16. Lang H., Gunzer G., Hennrich N., Neumann S., Faitz H., Jochum M. Granulocyte enzymes and inflammatory diseases. Froeschle M.C., Goetz W.A. Elastase: A New Marker for Inflammatory Diseases. 1985;1-14 GIT Verlag, Darmstadt Germany.
17. Maes M., Lambrechts J., Bosmans E., Jacobs J., Suy E., Vandervorst C., et al. Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjuction with monoclonal antibody staining. Psychol. Med. 22:1992;45-53.
18. Maes M., Van der Planken M., Stevens W., Peeters D., De Clerck L., Bndts C., et al. Leukocytosis, monocytosis and neutrophilia: Hallmarks of severe depression. J. Psychiatr. Res. 26:1992;125-134.
19. Maes M., Stevens W., DeClerck L., Bndts C., Peeters D., Schotte C., et al. Immune disorders in depression: Higher T helper/T supressor-cytotoxic cell ratio. Acta Psychiatr. Scand. 86:1992;423-431.
20. Maes M., Stevens W.J., DeClerck L.S., Bndts C., Peeters D., Schotte C., et al. A significantly increased number and percentage of B cell in depressed subjects: results of flow cytometric measurements. J. Affective Disord. 24:1992;127-134.
21. Maes M., Scharpe S., Meltzer H.Y., Bosmans E., Calabrese J., Cosyns P. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res. 49:1993;11-27.
22. Maes M., Meltzer H.Y., Jacobs J., Suy E., Calabrese J., Minner B., Raus J. Autoimmunity in depression: increased antiphospholipid autoantibody titers. Acta Psychiatr. Scand. 87:1993;160-166.
23. Maes M., Scharpe S., Meltzer H.Y., Cosyns P. Relationships between increased haptoglobulin plasma levels and activation of cell-mediated immunity in depression. Biol. Psychiatry. 34:1993;690-701.
24. Maes M., Meltzer H.Y., Buckley P., Bosmans E. Plasma soluble interleukin-2 and transferrin receptor in schizophrenia and major depression. Eur. Arch. Psychiatry Clin. Neurosci. 24:1995;325-329.
25. Maes M., Delange J., Ranjan R., Meltzer H.Y., Desnyder R., Cooreman W., Scharpe S. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res. 66:1997;1-11.
26. 1-proteinase inhibitor complex. Vol. V:1988;184-195 VCH Verlagsgesellschaft, Weinheim, Germany.
27. Orem A., Deger O., Çimçit G., Bahadir S. Plasma PMN leukocyte elastase levels and its relation to disease activity in psoriasis. Clin. Chim. Acta. 264:1997;49-56.
28. Post R.M. Kaplan H.I., Saddock B.J. Comprehensive Textbook of Psychiatry. 6th ed Mood disorder: somatic treatment. Vol 1:1995;1152-1178 Williams & Wilkins, Baltimore.
29. Prowse K.R., Baumann H. Interleukin-1 and interleukin-6 stimulate acute phase protein production in primary mouse hepatocyte. J. Leukocyte Biol. 45:1989;55-61.
30. Sluzewska A., Rybakokowski J., Bosmans E. Indicator of immune activator in major depression. Psychiatry Res. 64:1996;161-167.
31. Song C., Dinan T., Leonard B.E. Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J. Affect. Disord. 30:1994;283-288.
32. Song C., Leonard B.E. An acute phase protein response in the olfactory bulbectomised rat: effect of sertraline treatment. Med. Sci. Res. 22:1994;313-314.
33. Van-Hunsel F., Wauters A., Vandoolaeghe E. Lower serum total protein, albumin, and beta and gamma globulin in major and treatment resistant depression: effects of antidepressant treatments. Psychiatry Res. 65:1996;159-169.
34. Williams J.W.B. A structured interview guide for the Hamilton Depression Rating Scale. Arch. Gen. Psychiatry. 45:1988;742-747.
35. Xia Z., Appelkvist E.L., DePierre J.W. Tricyclic antidepressant-induced lipidosis in human peripheral monocytes in vitro, as well as in a monocyte-derived cell line, as monitored by spectrofluonmetry after staining with Nile red. Biochem. Pharmacol. 53:1997;1521-1532.